Neogenomics (NEO) Market Capitalization (2010 - 2026)

Neogenomics (NEO) has reported Market Capitalization for 17 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 98.4% year-over-year to $1.9 billion; the trailing twelve-month figure through Jun 2026 stood at $1.9 billion (up 98.4% YoY), and the FY2025 full-year result was $1.5 billion, down 28.17% from the prior year.
• Market Capitalization rose to $1.9 billion in Q2 2026 per NEO's latest filing, from $962.0 million in the prior quarter.
• Across five years, Market Capitalization topped out at $2.2 billion in Q1 2023 and bottomed at $940.7 million in Q2 2025.
• Historically, Market Capitalization has averaged $1.6 billion across 5 years, with a median of $1.5 billion in 2023.
• The sharpest annual moves came in 2022 and 2023: Market Capitalization sank 81.67% in 2022, then surged 99.48% in 2023.
• Over 5 years, Market Capitalization stood at $1.2 billion in 2022, then surged by 75.74% to $2.1 billion in 2023, then grew by 2.47% to $2.1 billion in 2024, then dropped by 28.17% to $1.5 billion in 2025, then advanced by 23.03% to $1.9 billion in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $1.9 billion, $962.0 million, and $1.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.